| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PNAS..110E..15T |
| P356 | DOI | 10.1073/PNAS.1214638110 |
| P932 | PMC publication ID | 3538218 |
| P698 | PubMed publication ID | 23236148 |
| P50 | author | Stephen Mayfield | Q100916483 |
| P2093 | author name string | Jack Bui | |
| Daniel J Barrera | |||
| Pär L Pettersson | |||
| Carlos D Peinado | |||
| Christina Van | |||
| Miller Tran | |||
| P2860 | cites work | Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission | Q21134576 |
| Structure of the chloroplast ribosome: novel domains for translation regulation | Q21563567 | ||
| The codon Adaptation Index--a measure of directional synonymous codon usage bias, and its potential applications | Q24498207 | ||
| Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain | Q70391584 | ||
| Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies | Q71721160 | ||
| Light-regulated translation of chloroplast messenger RNAs through redox potential | Q72886749 | ||
| Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys | Q74605039 | ||
| [Antibody-drug conjugate--a new age for personalized cancer treatment] | Q82189850 | ||
| Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression | Q84702932 | ||
| Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii | Q24633871 | ||
| Pathways for protein disulphide bond formation | Q28141294 | ||
| Biofuels from algae: challenges and potential | Q28741661 | ||
| Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast | Q33278598 | ||
| Plant organelles contain distinct peptidylprolyl cis,trans-isomerases | Q33971071 | ||
| Immunotoxin treatment of cancer | Q34000417 | ||
| Micro-algae come of age as a platform for recombinant protein production | Q34134908 | ||
| Exploiting diversity and synthetic biology for the production of algal biofuels | Q34381010 | ||
| Robust expression and secretion of Xylanase1 in Chlamydomonas reinhardtii by fusion to a selection gene and processing with the FMDV 2A peptide | Q34399087 | ||
| Antibody-drug conjugates: targeted drug delivery for cancer | Q34621670 | ||
| The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics | Q35078976 | ||
| Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases | Q35377867 | ||
| Prospects for molecular farming in the green alga Chlamydomonas | Q35683391 | ||
| Plastid transformation in higher plants | Q35891630 | ||
| A recombinant immunotoxin containing a disulfide-stabilized Fv fragment | Q36476431 | ||
| Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes | Q36588550 | ||
| Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | Q36670217 | ||
| Chlamydomonas reinhardtii chloroplasts as protein factories. | Q36743031 | ||
| CAIcal: a combined set of tools to assess codon usage adaptation | Q36909725 | ||
| Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity | Q36923799 | ||
| The next generation of antibody-drug conjugates comes of age | Q37804936 | ||
| Brentuximab vedotin: a new age in the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma | Q37991128 | ||
| Recombinant RFB4 single-chain immunotoxin that is cytotoxic towards CD22-positive cells | Q38346252 | ||
| Recombinant, ETA'-based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice | Q39709888 | ||
| Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor | Q42217000 | ||
| Intrachain disulfide bond in the core hinge region of human IgG4. | Q42268343 | ||
| Chloroplast elongation factor ts pro-protein is an evolutionarily conserved fusion with the s1 domain-containing plastid-specific ribosomal protein-7. | Q42640775 | ||
| Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas | Q43764951 | ||
| Bivalent disulfide-stabilized fragment variable immunotoxin directed against mesotheliomas and ovarian cancer | Q44239198 | ||
| Pharmacokinetics and biodistribution of the antitumor immunoconjugate, cantuzumab mertansine (huC242-DM1), and its two components in mice | Q44666449 | ||
| Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts | Q44890114 | ||
| Chaperone over-expression in Escherichia coli: apparent increased yields of soluble recombinant protein kinases are due mainly to soluble aggregates | Q46225519 | ||
| A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin | Q46249887 | ||
| Development of a luciferase reporter gene, luxCt, for Chlamydomonas reinhardtii chloroplast | Q47255593 | ||
| Protein disulfide isomerase as a regulator of chloroplast translational activation | Q48041388 | ||
| Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicity. | Q54549434 | ||
| Recombinant RFB4 immunotoxins exhibit potent cytotoxic activity for CD22-bearing cells and tumors. | Q54559094 | ||
| The Chlamydomonas genome reveals its secrets: chaperone genes and the potential roles of their gene products in the chloroplast. | Q55041195 | ||
| Brentuximab vedotin. | Q55055491 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | E15-22 | |
| P577 | publication date | 2012-12-10 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Production of unique immunotoxin cancer therapeutics in algal chloroplasts | |
| P478 | volume | 110 |
| Q39092873 | Advances in Anticancer Protein Delivery Using Micro-/ Nanoparticles |
| Q47341896 | Alga-Made Anti-Hepatitis B Antibody Binds to Human Fcγ Receptors. |
| Q36970645 | Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines |
| Q36207498 | Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin |
| Q38195781 | Algal omics: unlocking bioproduct diversity in algae cell factories |
| Q45960456 | An improved ARS2-derived nuclear reporter enhances the efficiency and ease of genetic engineering in Chlamydomonas. |
| Q38591992 | Biotechnological exploitation of microalgae. |
| Q59812062 | CITRIC: cold-inducible translational readthrough in the chloroplast of Chlamydomonas reinhardtii using a novel temperature-sensitive transfer RNA |
| Q74435848 | Cancer drugs from algae |
| Q38340182 | Chlamydomonas as a model for biofuels and bio-products production. |
| Q38797605 | Cisgenesis and intragenesis in microalgae: promising advancements towards sustainable metabolites production. |
| Q48097183 | Comparison of secretory signal peptides for heterologous protein expression in microalgae: Expanding the secretion portfolio for Chlamydomonas reinhardtii |
| Q58763821 | Constitutive and Chloroplast Targeted Expression of Acetyl-CoA Carboxylase in Oleaginous Microalgae Elevates Fatty Acid Biosynthesis |
| Q34213138 | Construction of novel chloroplast expression vector and development of an efficient transformation system for the diatom Phaeodactylum tricornutum |
| Q38177668 | Developing inexpensive malaria vaccines from plants and algae |
| Q92190998 | Downstream Processing of Chlamydomonas reinhardtii TN72 for Recombinant Protein Recovery |
| Q91636396 | Emerging Technologies in Algal Biotechnology: Toward the Establishment of a Sustainable, Algae-Based Bioeconomy |
| Q26749014 | Energy-efficient biomass processing with pulsed electric fields for bioeconomy and sustainable development |
| Q52309377 | Engineering the Chloroplast Genome of Oleaginous Marine Microalga Nannochloropsis oceanica. |
| Q46066746 | Expanding the spectral palette of fluorescent proteins for the green microalga Chlamydomonas reinhardtii. |
| Q52597279 | Expression of VGRNb-PE immunotoxin in transplastomic lettuce (Lactuca sativa L.). |
| Q38126016 | Expression of recombinant antibodies |
| Q51075442 | Flow process for electroextraction of total proteins from microalgae. |
| Q38696255 | From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein |
| Q28539699 | Gateway-assisted vector construction to facilitate expression of foreign proteins in the chloroplast of single celled algae |
| Q38344906 | Genes involved in the endoplasmic reticulum N-glycosylation pathway of the red microalga Porphyridium sp.: a bioinformatic study |
| Q40409023 | Genomic Foundation of Starch-to-Lipid Switch in Oleaginous Chlorella spp. |
| Q47689800 | Green biologics: The algal chloroplast as a platform for making biopharmaceuticals |
| Q37166841 | Heterologous overexpression of sfCherry fluorescent protein in Nannochloropsis salina |
| Q92163362 | Hosts for Hostile Protein Production: The Challenge of Recombinant Immunotoxin Expression |
| Q36959363 | Immuno-targeting the multifunctional CD38 using nanobody |
| Q38831292 | Microalgae as Solar-Powered Protein Factories |
| Q38722735 | Microalgal bioengineering for sustainable energy development: Recent transgenesis and metabolic engineering strategies |
| Q30252148 | Molecular farming on rescue of pharma industry for next generations. |
| Q36924094 | New tools for chloroplast genetic engineering allow the synthesis of human growth hormone in the green alga Chlamydomonas reinhardtii |
| Q64027810 | On-cell catalysis by surface engineering of live cells with an artificial metalloenzyme |
| Q38371816 | Outlook in the application of Chlamydomonas reinhardtii chloroplast as a platform for recombinant protein production |
| Q90163464 | Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae |
| Q38198558 | Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses |
| Q38896345 | Pilot-scale cultivation of wall-deficient transgenic Chlamydomonas reinhardtii strains expressing recombinant proteins in the chloroplast. |
| Q50238334 | Production of Recombinant Proteins in the Chloroplast of the Green Alga Chlamydomonas reinhardtii |
| Q39146031 | Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners. |
| Q42202179 | Production of recombinant proteins in microalgae at pilot greenhouse scale |
| Q34038327 | Production of therapeutic proteins in the chloroplast of Chlamydomonas reinhardtii |
| Q34054932 | Protein N-glycosylation in eukaryotic microalgae and its impact on the production of nuclear expressed biopharmaceuticals. |
| Q39253743 | Recent achievements obtained by chloroplast transformation. |
| Q57477762 | Selectable Markers and Reporter Genes for Engineering the Chloroplast of |
| Q35811865 | Selenocystamine improves protein accumulation in chloroplasts of eukaryotic green algae |
| Q55244022 | Targeted delivery of fluorogenic peptide aptamers into live microalgae by femtosecond laser photoporation at single-cell resolution. |
| Q26744351 | The Potential for Microalgae as Bioreactors to Produce Pharmaceuticals |
| Q28659329 | The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life |
Search more.